ELVN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 3.00%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $19,593,689.68

Enliven Therapeutics Insider Trading History Chart

Enliven Therapeutics Share Price & Price History

^$50.81

▲ +0.571 (1.14%)

As of 09/18/2026 11:40 AM ET

Days: 30 | 90 | 365

Enliven Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/17/2026	Benjamin Hohl	CFO	Sell	6,018	$58.58	$352,534.44	40,036
8/4/2026	Mika Kakefuda Derynck	Director	Sell	158,795	$60.21	$9,561,046.95	87,373
7/17/2026	Benjamin Hohl	CFO	Sell	6,018	$52.64	$316,787.52	46,054
7/6/2026	Lori Anne Kunkel	Director	Sell	10,000	$50.49	$504,900.00	41,884
6/17/2026	Benjamin Hohl	CFO	Sell	6,018	$43.80	$263,588.40	51,000
6/5/2026	Lori Anne Kunkel	Director	Sell	10,000	$34.54	$345,400.00	51,884
3/6/2026	Benjamin Hohl	CFO	Sell	10,000	$29.58	$295,800.00	51,000
2/17/2026	Richard A. Heyman	Director	Sell	1,230	$26.18	$32,201.40	22,647
2/6/2026	Joseph P. Lyssikatos	Insider	Sell	5,000	$29.04	$145,200.00	740,188
1/20/2026	Joseph P. Lyssikatos	Insider	Sell	20,000	$26.75	$535,000.00	745,188
1/20/2026	Richard A. Heyman	Director	Sell	1,230	$26.75	$32,902.50	23,877
1/9/2026	Anish Patel	COO	Sell	48,300	$27.99	$1,351,917.00	215,011
1/9/2026	Joseph P. Lyssikatos	Insider	Sell	91,198	$27.22	$2,482,409.56	765,188
1/9/2026	Richard A. Heyman	Director	Sell	4,285	$25.00	$107,125.00	25,107
1/8/2026	Joseph P. Lyssikatos	Insider	Sell	41,302	$24.05	$993,313.10	856,386
1/8/2026	Richard A. Heyman	Director	Sell	9,635	$25.03	$241,164.05	25,545
12/19/2025	Joseph P. Lyssikatos	Insider	Sell	5,000	$16.84	$84,200.00	897,688
12/8/2025	Anish Patel	COO	Sell	6,663	$21.02	$140,056.26	263,311
11/19/2025	Joseph P. Lyssikatos	Insider	Sell	12,500	$22.33	$279,125.00	902,688
11/17/2025	Samuel Kintz	CEO	Sell	12,500	$21.82	$272,750.00	890,392
11/7/2025	Anish Patel	COO	Sell	6,667	$17.40	$116,005.80	269,974
10/20/2025	Joseph P. Lyssikatos	Insider	Sell	12,500	$22.08	$276,000.00	915,188
10/17/2025	Samuel Kintz	CEO	Sell	12,500	$21.33	$266,625.00	902,892
10/7/2025	Anish Patel	COO	Sell	6,667	$20.10	$134,006.70	276,641
9/29/2025	Benjamin Hohl	CFO	Sell	3,250	$20.40	$66,300.00	23,000
9/26/2025	Joseph P. Lyssikatos	Insider	Sell	4,000	$20.25	$81,000.00	927,688
9/26/2025	Samuel Kintz	CEO	Sell	3,700	$20.06	$74,222.00	915,392
9/23/2025	Joseph P. Lyssikatos	Insider	Sell	1,500	$20.03	$30,045.00	931,688
9/23/2025	Samuel Kintz	CEO	Sell	2,800	$20.03	$56,084.00	919,092
9/19/2025	Joseph P. Lyssikatos	Insider	Sell	7,000	$19.39	$135,730.00	933,188
9/19/2025	Samuel Kintz	CEO	Sell	1,000	$20.25	$20,250.00	921,892
9/17/2025	Samuel Kintz	CEO	Sell	5,000	$19.09	$95,450.00	922,892
9/8/2025	Anish Patel	COO	Sell	6,667	$20.24	$134,940.08	283,308
8/27/2025	Benjamin Hohl	CFO	Sell	3,250	$20.63	$67,047.50	23,000
8/21/2025	Joseph P. Lyssikatos	Insider	Sell	7,500	$20.01	$150,075.00	940,188
8/19/2025	Joseph P. Lyssikatos	Insider	Sell	5,000	$19.62	$98,100.00	947,688
8/19/2025	Samuel Kintz	CEO	Sell	590	$20.00	$11,800.00	929,409
8/18/2025	Samuel Kintz	CEO	Sell	10,393	$20.02	$208,067.86	929,999
8/7/2025	Anish Patel	COO	Sell	6,667	$18.24	$121,606.08	289,975
7/28/2025	Benjamin Hohl	CFO	Sell	3,250	$20.46	$66,495.00	23,000
7/21/2025	Joseph P. Lyssikatos	Insider	Sell	12,500	$22.29	$278,625.00	952,688
7/17/2025	Samuel Kintz	CEO	Sell	12,500	$22.52	$281,500.00	940,392
7/10/2025	Benjamin Hohl	CFO	Sell	1,000	$22.66	$22,660.00	23,000
7/7/2025	Anish Patel	COO	Sell	6,667	$19.79	$131,939.93	296,642
6/27/2025	Benjamin Hohl	CFO	Sell	3,250	$20.91	$67,957.50	23,000
6/20/2025	Joseph P. Lyssikatos	Insider	Sell	12,500	$21.40	$267,500.00	965,188
6/17/2025	Samuel Kintz	CEO	Sell	12,500	$22.18	$277,250.00	952,892
6/9/2025	Anish Patel	COO	Sell	6,667	$20.34	$135,606.78	303,309
6/3/2025	Joseph P. Lyssikatos	Insider	Sell	7,500	$20.03	$150,225.00	977,688
6/3/2025	Samuel Kintz	CEO	Sell	7,500	$20.05	$150,375.00	965,392
5/27/2025	Benjamin Hohl	CFO	Sell	3,250	$16.18	$52,585.00	23,000
5/19/2025	Joseph P. Lyssikatos	Insider	Sell	5,000	$16.31	$81,550.00	985,188
5/19/2025	Samuel Kintz	CEO	Sell	5,000	$16.49	$82,450.00	972,892
5/7/2025	Anish Patel	COO	Sell	6,667	$18.39	$122,606.13	309,976
5/1/2025	Joseph P. Lyssikatos	Insider	Sell	5,030	$20.07	$100,952.10	992,658
5/1/2025	Samuel Kintz	CEO	Sell	5,330	$20.08	$107,026.40	980,062
4/28/2025	Benjamin Hohl	CFO	Sell	3,250	$18.69	$60,742.50	23,000
4/21/2025	Joseph P. Lyssikatos	Insider	Sell	5,000	$16.07	$80,350.00	997,688
4/17/2025	Samuel Kintz	CEO	Sell	5,000	$16.42	$82,100.00	985,392
4/7/2025	Anish Patel	COO	Sell	6,667	$18.04	$120,272.68	316,643
3/27/2025	Benjamin Hohl	CFO	Sell	3,250	$21.33	$69,322.50	23,000
3/24/2025	Benjamin Hohl	CFO	Sell	1,000	$22.50	$22,500.00	23,000
3/19/2025	Joseph P. Lyssikatos	Insider	Sell	12,500	$20.61	$257,625.00	1,002,688
3/17/2025	Samuel Kintz	CEO	Sell	12,500	$20.83	$260,375.00	990,392
3/7/2025	Anish Patel	COO	Sell	6,667	$21.44	$142,940.48	323,310
2/27/2025	Benjamin Hohl	CFO	Sell	3,250	$20.41	$66,332.50	13,000
2/7/2025	Anish Patel	COO	Sell	6,667	$21.93	$146,207.31	329,977
2/5/2025	Benjamin Hohl	CFO	Sell	1,000	$22.52	$22,520.00	13,000
1/27/2025	Benjamin Hohl	CFO	Sell	3,250	$21.59	$70,167.50	13,000
1/7/2025	Anish Patel	COO	Sell	21,700	$24.18	$524,706.00
1/3/2025	Benjamin Hohl	CFO	Sell	1,000	$25.04	$25,040.00	13,000
12/30/2024	Benjamin Hohl	CFO	Sell	900	$22.51	$20,259.00
12/27/2024	Benjamin Hohl	CFO	Sell	3,350	$22.15	$74,202.50
11/27/2024	Benjamin Hohl	CFO	Sell	5,250	$24.89	$130,672.50
10/28/2024	Benjamin Hohl	CFO	Sell	6,250	$28.56	$178,500.00
10/18/2024	Anish Patel	COO	Sell	716	$30.00	$21,480.00	343,311
10/18/2024	Benjamin Hohl	CFO	Sell	814	$30.00	$24,420.00
10/18/2024	Joseph P. Lyssikatos	Insider	Sell	847	$30.00	$25,410.00	1,015,188
10/18/2024	Richard A. Heyman	Director	Sell	817	$30.00	$24,510.00	123,673
10/18/2024	Samuel Kintz	CEO	Sell	924	$30.00	$27,720.00	1,002,892
10/15/2024	Richard A. Heyman	Director	Sell	1,270	$27.67	$35,140.90	124,490
10/9/2024	Joseph P. Lyssikatos	Insider	Sell	37,878	$28.16	$1,066,644.48	1,016,035
10/9/2024	Samuel Kintz	CEO	Sell	16,710	$28.15	$470,386.50	1,003,816
10/8/2024	Rahul D. Ballal	Director	Sell	10,420	$28.17	$293,531.40	22,341
10/7/2024	Benjamin Hohl	CFO	Sell	1,270	$27.51	$34,937.70
10/7/2024	Joseph P. Lyssikatos	Insider	Sell	2,707	$27.61	$74,740.27	1,067,180
10/7/2024	Samuel Kintz	CEO	Sell	2,730	$27.50	$75,075.00	1,033,793
10/4/2024	Benjamin Hohl	CFO	Sell	10,218	$27.51	$281,097.18
10/4/2024	Joseph P. Lyssikatos	Insider	Sell	7,522	$27.51	$206,930.22	1,069,887
10/4/2024	Richard A. Heyman	Director	Sell	2,825	$27.51	$77,715.75	125,760
10/4/2024	Samuel Kintz	CEO	Sell	12,206	$27.51	$335,787.06	1,036,523
10/1/2024	Joseph P. Lyssikatos	Insider	Sell	527	$27.54	$14,513.58	1,077,409
10/1/2024	Richard A. Heyman	Director	Sell	518	$27.54	$14,265.72	128,585
10/1/2024	Samuel Kintz	CEO	Sell	526	$27.54	$14,486.04	1,048,729
9/30/2024	Benjamin Hohl	CFO	Sell	2,000	$25.33	$50,660.00
9/27/2024	Benjamin Hohl	CFO	Sell	4,250	$24.27	$103,147.50
8/29/2024	Joseph P. Lyssikatos	Insider	Sell	12,000	$22.49	$269,880.00	1,077,936
8/27/2024	Benjamin Hohl	CFO	Sell	4,250	$22.54	$95,795.00
8/26/2024	Samuel Kintz	CEO	Sell	12,000	$22.89	$274,680.00	1,049,255
8/15/2024	Richard A. Heyman	Director	Sell	1,270	$23.25	$29,527.50	130,373
7/31/2024	Benjamin Hohl	CFO	Sell	991	$27.53	$27,282.23
7/31/2024	Joseph P. Lyssikatos	Insider	Sell	3,099	$27.56	$85,408.44	1,089,936
7/31/2024	Richard A. Heyman	Director	Sell	1,702	$27.51	$46,822.02	131,643
7/31/2024	Samuel Kintz	CEO	Sell	2,270	$27.56	$62,561.20	1,061,255
7/29/2024	Benjamin Hohl	CFO	Sell	5,250	$26.68	$140,070.00
7/29/2024	Joseph P. Lyssikatos	Insider	Sell	12,000	$26.70	$320,400.00	1,093,035
7/25/2024	Samuel Kintz	CEO	Sell	12,000	$24.92	$299,040.00	1,063,525
7/15/2024	Anish Patel	COO	Sell	30,978	$25.05	$775,998.90	345,574
7/15/2024	Richard A. Heyman	Director	Sell	1,270	$24.80	$31,496.00	133,345
7/12/2024	Anish Patel	COO	Sell	17,475	$25.07	$438,098.25	376,552
7/12/2024	Benjamin Hohl	CFO	Sell	3,000	$25.07	$75,210.00
6/27/2024	Benjamin Hohl	CFO	Sell	4,250	$22.57	$95,922.50
6/25/2024	Samuel Kintz	CEO	Sell	12,000	$21.66	$259,920.00	1,075,525
6/6/2024	Anish Patel	COO	Sell	1,133	$20.06	$22,727.98
5/28/2024	Benjamin Hohl	CFO	Sell	4,250	$23.18	$98,515.00
5/28/2024	Samuel Kintz	CEO	Sell	12,000	$23.18	$278,160.00
5/16/2024	Rishi Gupta	Director	Sell	1,033,300	$22.14	$22,877,262.00	254,814
5/14/2024	Anish Patel	COO	Sell	1,107	$25.00	$27,675.00
5/9/2024	Anish Patel	COO	Sell	260	$25.06	$6,515.60
5/6/2024	Anish Patel	COO	Sell	4,875	$22.72	$110,760.00
5/3/2024	Benjamin Hohl	CFO	Sell	1,000	$22.50	$22,500.00
4/29/2024	Benjamin Hohl	CFO	Sell	3,250	$16.97	$55,152.50
4/29/2024	Joseph P. Lyssikatos	insider	Sell	12,000	$17.92	$215,040.00
4/25/2024	Samuel Kintz	CEO	Sell	12,000	$16.89	$202,680.00
4/15/2024	Richard A. Heyman	Director	Sell	1,270	$19.99	$25,387.30	137,155
4/11/2024	Anish Patel	COO	Sell	17,500	$25.03	$438,025.00
4/11/2024	Benjamin Hohl	CFO	Sell	14,000	$24.72	$346,080.00
4/11/2024	Joseph P. Lyssikatos	insider	Sell	30,000	$25.04	$751,200.00
4/11/2024	Rahul D. Ballal	Director	Sell	53,400	$23.95	$1,278,930.00	22,341
4/11/2024	Samuel Kintz	CEO	Sell	47,709	$25.04	$1,194,633.36
4/8/2024	Anish Patel	COO	Sell	4,875	$18.60	$90,675.00	2,597
4/4/2024	Rahul D. Ballal	Director	Sell	3,485	$19.15	$66,737.75	22,341
4/1/2024	Joseph P. Lyssikatos	insider	Sell	12,000	$18.60	$223,200.00
4/1/2024	Rahul D. Ballal	Director	Sell	3,237	$19.08	$61,761.96	22,341
3/27/2024	Benjamin Hohl	CFO	Sell	3,250	$18.25	$59,312.50
3/25/2024	Samuel Kintz	CEO	Sell	12,000	$17.56	$210,720.00
3/19/2024	Richard A. Heyman	Director	Sell	1,270	$14.50	$18,415.00	143,470
3/6/2024	Anish Patel	COO	Sell	4,875	$15.64	$76,245.00	7,472
2/29/2024	Joseph P. Lyssikatos	insider	Sell	12,000	$16.42	$197,040.00
2/27/2024	Benjamin Hohl	CFO	Sell	3,250	$16.97	$55,152.50
2/15/2024	Richard A. Heyman	Director	Sell	1,270	$17.42	$22,123.40	144,740
2/6/2024	Anish Patel	COO	Sell	4,875	$15.11	$73,661.25	12,347
1/31/2024	5Am Partners Vi, Llc	Major Shareholder	Sell	500,000	$15.00	$7,500,000.00	771,983
1/30/2024	Richard A. Heyman	Director	Sell	1,270	$16.41	$20,840.70	146,010
1/29/2024	Benjamin Hohl	CFO	Sell	3,250	$15.81	$51,382.50
1/29/2024	Joseph P. Lyssikatos	insider	Sell	12,000	$15.85	$190,200.00
1/25/2024	Samuel Kintz	CEO	Sell	12,000	$15.69	$188,280.00
1/22/2024	Anish Patel	COO	Sell	4,875	$15.13	$73,758.75	17,222
1/2/2024	Anish Patel	COO	Sell	11,000	$15.00	$165,000.00	22,097
1/2/2024	Benjamin Hohl	CFO	Sell	9,383	$15.01	$140,838.83
12/26/2023	Anish Patel	COO	Sell	102	$15.01	$1,531.02	35,637
12/26/2023	Benjamin Hohl	CFO	Sell	100	$15.00	$1,500.00
12/26/2023	Samuel Kintz	CEO	Sell	12,000	$14.64	$175,680.00
12/22/2023	Anish Patel	COO	Sell	983	$15.03	$14,774.49	35,739
12/22/2023	Benjamin Hohl	CFO	Sell	1,030	$15.07	$15,522.10
12/22/2023	Samuel Kintz	CEO	Sell	8,175	$13.05	$106,683.75
12/21/2023	Joseph P. Lyssikatos	insider	Sell	20	$13.00	$260.00
12/21/2023	Richard A. Heyman	Director	Sell	7	$13.00	$91.00	147,448
12/20/2023	Samuel Kintz	CEO	Sell	7,779	$13.01	$101,204.79
12/19/2023	Joseph P. Lyssikatos	insider	Sell	200	$13.00	$2,600.00
12/19/2023	Richard A. Heyman	Director	Sell	255	$13.00	$3,315.00	149,565
11/3/2023	Joseph P. Lyssikatos	insider	Sell	8,546	$13.08	$111,781.68
11/3/2023	Samuel Kintz	CEO	Sell	8,026	$13.08	$104,980.08
9/29/2023	Joseph P. Lyssikatos	insider	Sell	12,000	$13.62	$163,440.00
9/26/2023	5Am Partners Vi, Llc	Major Shareholder	Sell	197,500	$15.00	$2,962,500.00	854,796
9/25/2023	Samuel Kintz	CEO	Sell	12,000	$13.81	$165,720.00

SEC Filings (Institutional Ownership Changes) for Enliven Therapeutics (NASDAQ:ELVN)

95.08% of Enliven Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Enliven Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
9/9/2026	First Light Asset Management LLC	1,360,750	$69.06M	4.2%	+574.1%	1.857%
9/9/2026	Tidal Investments LLC	60,694	$3.08M	0.0%	+27.7%	0.083%
9/9/2026	WINTON GROUP Ltd	4,495	$0.23M	0.0%	N/A	0.006%
9/9/2026	Engineers Gate Manager LP	29,152	$1.48M	0.0%	N/A	0.040%
9/9/2026	Squarepoint Ops LLC	5,099	$0.26M	0.0%	N/A	0.007%
9/8/2026	Arizona State Retirement System	13,007	$0.66M	0.0%	+45.1%	0.018%
9/2/2026	Allianz Asset Management GmbH	52,008	$2.64M	0.0%	N/A	0.071%
8/26/2026	Amundi	6,041	$0.31M	0.0%	-12.9%	0.008%
8/21/2026	AXQ Capital LP	10,095	$0.51M	0.1%	-5.1%	0.014%
8/19/2026	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	80,072	$4.06M	0.0%	+18.7%	0.109%
8/19/2026	Wellington Management Group LLP	133,143	$6.76M	0.0%	-11.3%	0.182%
8/17/2026	Capstone Investment Advisors LLC	10,577	$0.54M	0.0%	N/A	0.014%
8/17/2026	Seven Fleet Capital Management LP	365,386	$18.54M	3.1%	+40.9%	0.499%
8/17/2026	Artia Global Partners LP	72,100	$3.66M	0.7%	N/A	0.098%
8/17/2026	Bamco Inc. NY	7,500	$0.38M	0.0%	N/A	0.010%
8/17/2026	Bank of America Corp DE	98,023	$4.98M	0.0%	N/A	0.134%
8/15/2026	Jupiter Topco LLC	604,122	$30.62M	0.0%	N/A	0.825%
8/15/2026	J. Goldman & Co LP	112,129	$5.69M	0.1%	N/A	0.153%
8/14/2026	ADAR1 Capital Management LLC	387,718	$19.68M	0.9%	N/A	0.529%
8/14/2026	Canada Pension Plan Investment Board	15,400	$0.78M	0.0%	N/A	0.021%
8/14/2026	Nicholas Investment Partners LP	391,529	$19.87M	1.1%	N/A	0.534%
8/14/2026	Legal & General Group Plc	32,924	$1.67M	0.0%	N/A	0.045%
8/14/2026	The Manufacturers Life Insurance Company	75,265	$3.82M	0.0%	N/A	0.103%
8/14/2026	Spruce Street Capital LP	329,006	$16.70M	0.0%	N/A	0.449%
8/14/2026	Algert Global LLC	72,090	$3.66M	0.0%	N/A	0.098%
8/13/2026	Connor Clark & Lunn Investment Management Ltd.	160,879	$8.17M	0.0%	N/A	0.220%
8/7/2026	BlackRock Inc.	4,359,704	$221.26M	0.0%	N/A	7.159%
8/7/2026	Deutsche Bank AG	45,109	$2.29M	0.0%	N/A	0.074%
8/7/2026	TimesSquare Capital Management LLC	261,344	$13.26M	0.2%	N/A	0.429%
8/7/2026	Persistent Asset Partners Ltd	9,433	$0.48M	0.1%	N/A	0.015%
8/6/2026	Bank of New York Mellon Corp	118,853	$6.03M	0.0%	N/A	0.195%
8/6/2026	State of Wyoming	1,884	$96K	0.0%	N/A	0.003%
7/10/2026	Tema ETFs LLC	60,694	$3.08M	0.1%	+41.0%	0.100%
7/10/2026	Handelsbanken Fonder AB	17,300	$0.88M	0.0%	N/A	0.028%
7/8/2026	FNY Investment Advisers LLC	2,500	$0.13M	0.0%	N/A	0.004%
7/8/2026	Assenagon Asset Management S.A.	306,574	$15.56M	0.0%	N/A	0.503%
6/4/2026	Seven Fleet Capital Management LP	259,283	$10.16M	3.2%	+159.4%	0.426%
6/3/2026	DV Trading LLC	95,253	$3.73M	0.1%	N/A	0.156%
5/28/2026	Avidity Partners Management LP	400,000	$15.68M	3.1%	+185.1%	0.657%
5/19/2026	Bank of America Corp DE	45,162	$1.77M	0.0%	+38.1%	0.074%
5/19/2026	Stempoint Capital LP	363,438	$14.25M	2.7%	N/A	0.597%
5/19/2026	Janus Henderson Group PLC	11,000	$0.43M	0.0%	-99.3%	0.018%
5/18/2026	ADAR1 Capital Management LLC	329,540	$12.92M	0.8%	+998.5%	0.541%
5/18/2026	Amundi	6,936	$0.27M	0.0%	N/A	0.011%
5/18/2026	California State Teachers Retirement System	31,914	$1.25M	0.0%	-0.9%	0.052%
5/18/2026	Royal Bank of Canada	5,424	$0.21M	0.0%	+345.0%	0.009%
5/18/2026	Rock Springs Capital Management LP	826,500	$32.40M	1.9%	+3.5%	1.357%
5/18/2026	Exome Asset Management LLC	220,091	$8.63M	4.5%	-1.0%	0.361%
5/16/2026	The Manufacturers Life Insurance Company	23,441	$0.92M	0.0%	+21.2%	0.038%
5/16/2026	Quantinno Capital Management LP	6,538	$0.26M	0.0%	N/A	0.011%
5/16/2026	First Light Asset Management LLC	201,867	$7.91M	0.7%	N/A	0.331%
5/16/2026	SummitTX Capital L.P.	68,706	$2.69M	0.1%	N/A	0.113%
5/15/2026	Commodore Capital LP	3,275,000	$128.38M	7.4%	-30.2%	5.378%
5/15/2026	Affinity Asset Advisors LLC	586,904	$23.01M	1.2%	N/A	0.964%
5/15/2026	Entropy Technologies LP	6,101	$0.24M	0.0%	N/A	0.010%
5/15/2026	Spruce Street Capital LP	329,006	$12.90M	3.1%	-26.2%	0.540%
5/14/2026	Siren L.L.C.	746,226	$29.25M	0.8%	N/A	1.225%
5/14/2026	Walleye Capital LLC	37,827	$1.48M	0.0%	N/A	0.062%
5/7/2026	Dimensional Fund Advisors LP	681,715	$26.71M	0.0%	+70.9%	1.119%
5/7/2026	KBC Group NV	958	$38K	0.0%	N/A	0.002%
5/6/2026	Jennison Associates LLC	309,180	$12.12M	0.0%	N/A	0.508%
5/5/2026	Bank of New York Mellon Corp	120,057	$4.71M	0.0%	+8.6%	0.197%
5/1/2026	Candriam S.C.A.	594,079	$23.29M	0.1%	+31.1%	0.975%
4/24/2026	Capricorn Fund Managers Ltd	369,400	$14.48M	2.3%	N/A	0.607%
4/22/2026	Pictet Asset Management Holding SA	929,544	$36.44M	0.0%	-28.7%	1.526%
2/26/2026	Seven Fleet Capital Management LP	11,688	$0.18M	0.1%	N/A	0.020%
2/19/2026	Invesco Ltd.	24,720	$0.38M	0.0%	+7.0%	0.042%
2/18/2026	XTX Topco Ltd	60,702	$0.94M	0.0%	+472.6%	0.102%
2/18/2026	Vestal Point Capital LP	3,830,000	$58.98M	2.0%	+230.2%	6.454%
2/18/2026	Virtus Investment Advisers LLC	15,778	$0.24M	0.1%	+172.6%	0.027%
2/18/2026	Wellington Management Group LLP	129,876	$2M	0.0%	+19.6%	0.219%
2/18/2026	Susquehanna Portfolio Strategies LLC	48,741	$0.75M	0.0%	+53.6%	0.082%
2/18/2026	Tudor Investment Corp ET AL	29,673	$0.46M	0.0%	+82.0%	0.050%
2/18/2026	Sphera Funds Management LTD.	226,765	$3.49M	0.7%	+36.0%	0.382%
2/18/2026	Millennium Management LLC	296,947	$4.57M	0.0%	-22.1%	0.500%
2/18/2026	Janus Henderson Group PLC	1,671,724	$25.75M	0.0%	-6.8%	2.817%
2/18/2026	Baker BROS. Advisors LP	271,406	$4.18M	0.0%	+136.3%	0.457%
2/17/2026	ADAR1 Capital Management LLC	30,000	$0.46M	0.0%	N/A	0.051%
2/17/2026	Jump Financial LLC	45,354	$0.70M	0.0%	N/A	0.076%
2/17/2026	Price T Rowe Associates Inc. MD	23,800	$0.37M	0.0%	-89.7%	0.040%
2/17/2026	Rock Springs Capital Management LP	798,405	$12.30M	0.6%	+16.4%	1.345%
2/17/2026	California State Teachers Retirement System	32,206	$0.50M	0.0%	+58.4%	0.054%
2/17/2026	Russell Investments Group Ltd.	3,121	$48K	0.0%	-14.3%	0.005%
2/17/2026	State of Wisconsin Investment Board	20,398	$0.31M	0.0%	-57.2%	0.034%
2/17/2026	ExodusPoint Capital Management LP	60,415	$0.93M	0.0%	+25.5%	0.102%
2/17/2026	Polar Capital Holdings Plc	3,513,680	$54.11M	0.2%	+13.5%	5.920%
2/16/2026	Squarepoint Ops LLC	20,763	$0.32M	0.0%	-42.1%	0.035%
2/16/2026	Spruce Street Capital LP	446,084	$6.87M	2.3%	N/A	0.752%
2/16/2026	Barclays PLC	69,875	$1.08M	0.0%	-1.2%	0.118%
2/13/2026	Marshall Wace LLP	371,906	$5.73M	0.0%	+9.2%	0.627%
2/13/2026	The Manufacturers Life Insurance Company	19,336	$0.30M	0.0%	-56.1%	0.033%
2/13/2026	Exome Asset Management LLC	222,308	$3.42M	1.6%	N/A	0.375%
2/13/2026	Charles Schwab Investment Management Inc.	355,192	$5.47M	0.0%	-2.2%	0.598%
2/13/2026	State Street Corp	1,052,862	$16.21M	0.0%	+9.1%	1.774%
2/13/2026	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	55,210	$0.85M	0.0%	+6.8%	0.093%
2/13/2026	Wells Fargo & Company MN	43,056	$0.66M	0.0%	+66.7%	0.073%
2/12/2026	Dimensional Fund Advisors LP	398,893	$6.14M	0.0%	+148.6%	0.672%
2/12/2026	Patient Square Capital LP	308,141	$4.75M	1.0%	+22.8%	0.519%
2/12/2026	New York State Common Retirement Fund	9,097	$0.14M	0.0%	-39.7%	0.015%
2/12/2026	Swiss National Bank	64,273	$0.99M	0.0%	+1.7%	0.108%

Data available starting January 2016

Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. The company's lead product candidates comprise ELVN-001, which is being evaluated in a Phase 1 clinical trial in adults with chronic myeloid leukemia; and ELVN-002, a Phase 1 clinical trial in adults with solid tumors with HER2 alterations. The company is headquartered in Boulder, Colorado.

Today's Range

Now: $50.81

$49.27

$51.20

50 Day Range

MA: $56.46

$49.12

$61.15

52 Week Range

Now: $50.81

$14.78

$62.32

Volume

202,103 shs

Average Volume

1,230,245 shs

Market Capitalization

$3.72 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.3

Who are the company insiders with the largest holdings of Enliven Therapeutics?: Enliven Therapeutics' top insider investors include:
Joseph P Lyssikatos (Insider)
Samuel Kintz (CEO)
5Am Partners Vi, Llc (Major Shareholder)
Anish Patel (COO)
Rishi Gupta (Director)
Richard A Heyman (Director)
Mika K Derynck (Director)
Lori Anne Kunkel (Director)
Benjamin Hohl (CFO)
Rahul D Ballal (Director)
Learn More about top insider investors at Enliven Therapeutics.
Who are the major institutional investors of Enliven Therapeutics?: Enliven Therapeutics' top institutional shareholders include:
BlackRock Inc. — 7.16%
First Light Asset Management LLC — 1.86%
Jupiter Topco LLC — 0.82%
Nicholas Investment Partners LP — 0.53%
ADAR1 Capital Management LLC — 0.53%
Seven Fleet Capital Management LP — 0.50%
Learn More about top institutional investors of Enliven Therapeutics stock.
Which institutional investors are selling Enliven Therapeutics stock?: Within the previous quarter, ELVN stock was sold by these institutional investors:
Wellington Management Group LLP
Amundi
AXQ Capital LP
In the previous year, company insiders that have sold Enliven Therapeutics company stock include:
Joseph P Lyssikatos (Insider)
Samuel Kintz (CEO)
Anish Patel (COO)
Mika K Derynck (Director)
Lori Anne Kunkel (Director)
Benjamin Hohl (CFO)
Richard A Heyman (Director)
Learn More investors selling Enliven Therapeutics stock.
Which institutional investors are buying Enliven Therapeutics stock?: During the previous quarter, ELVN stock was acquired by institutional investors including:
BlackRock Inc.
First Light Asset Management LLC
Jupiter Topco LLC
Nicholas Investment Partners LP
ADAR1 Capital Management LLC
Spruce Street Capital LP
Assenagon Asset Management S.A.
TimesSquare Capital Management LLC